| 1 |
Natalizumab-induced pneumonitis |
|
| | Stefania Kaninia, Anthony J. Edey, Nick A. Maskell, Claire M. Rice | | | Journal of Neurology. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Natalizumab induced blood eosinophilia: A retrospective pharmacovigilance cohort study and review of the literature |
|
| | L. Diem, R. Hoepner, M. Bagnoud, A. Salmen, A. Chan, C. Friedli | | | Journal of Neuroimmunology. 2021; 353: 577505 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Eosinophilia during natalizumab treatment: Incidence, risk factors and temporal patterns |
|
| | Milad-Kazava Keshvari, Frederick van Someren, Saima Sheikh, Ian Galea | | | Journal of Neuroimmunology. 2021; 361: 577729 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Noninfectious Pulmonary Complications Associated With Anti-Integrin Therapy: A Case Report and Systematic Review of the Literature |
|
| | David Dulaney, Priya Dave, Samantha Walsh, Saurabh Mehandru, Jean-Frederic Colombel, Manasi Agrawal | | | Inflammatory Bowel Diseases. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Eosinophilic fasciitis induced by natalizumab in a patient affected by multiple sclerosis |
|
| | Vincenzo Maione, Laura Miccio, Raffaella Sala, Claudia Zambelli, Piergiacomo Calzavara-Pinton | | | Indian Journal of Dermatology, Venereology and Leprology. 2021; 87: 146 | | | [Pubmed] [Google Scholar] [DOI] | |
|
